Introducing the Spinal Cord Neuromodulator (SCONE™)

An innovative device that treats urinary incontinence allowing people living with neurogenic bladder due to spinal cord injury, multiple sclerosis, or stroke to live their lives on their own terms. It is simple to use and results in lasting functional improvement.

SCONE™ has received FDA Breakthrough Device  Designation, meaning there is no similar competitive device on the market and the proposed therapy is significantly better than the current standard of care (SoC).

Neurogenic bladder

Neurogenic bladder (NB) is a common comorbidity that people experience after paralysis, stroke or alongside MS. It has the largest impact on their quality of life. Surveys suggest that individuals living with paralysis rate improvement in bladder, bowel and sexual function as a higher priority than restoration of their ability to walk, or even resolution of chronic pain.

How it works

SCONE™ therapy is delivered through comfortable hydrogel electrode pads that are placed on the skin over specific regions of the spinal column.

Treatment protocol

  • 60 minute session length
  • 2 sessions per week
  • 12 week program length

SCONE™ therapy results in global improvements

Reduced Urgency

Need for Fewer Catheters

Restored Sensation

Improved Capacity

Reduced Leaks

Reduced Frequency

No current SoC therapy can address all of these simultaneously.

Clinical trials

The SCONE™ study is actively recruiting at multiple sites across the US and globally.

SCONE™ has been recognized by the FDA as a breakthrough device

Bringing innovation to market

At SpineX, accessibility is key to our mission. We are pushing the boundaries of research to find the most effective solutions for patients with neurological conditions and, with our devices on the market, we will have the potential to impact millions of people around the world.

SCiP™ and SCONE™ are investigational devices and are limited by Federal (USA) law to investigational use only. The FDA has not reviewed the safety and efficacy for SCiP™ and SCONE™
To top